What You Should Know:
– Iris Telehealth, a leading provider of telepsychiatry services, announced the acquisition of innovaTel, a division of Quartet Health renowned for its expertise in treating complex mental health conditions. Financial details of the acquisition were not disclosed.
– The acquisition positions Iris Telehealth as one of the largest telepsychiatry companies in the nation, with a combined network of experienced clinicians and a comprehensive suite of services. This expanded reach will enable Iris Telehealth to better serve healthcare organizations and their patients, particularly in underserved communities facing a shortage of mental health professionals.
Addressing the Mental Health Provider Shortage
The need for mental health services is growing rapidly, but access to care remains a significant challenge. According to the Health Resources & Services Administration (HRSA), nearly 160 million Americans live in areas with a shortage of mental health providers.
By combining their resources and expertise, Iris Telehealth and innovaTel aim to bridge this gap and improve access to care for underserved populations. This acquisition will enable Iris Telehealth to:
- Expand its network of qualified clinicians: Increase the availability of telepsychiatry services to meet the growing demand.
- Enhance its clinical expertise: Leverage innovaTel’s specialized knowledge in treating complex mental health conditions.
- Strengthen its commitment to quality care: Maintain a focus on delivering exceptional patient care and outcomes.
“As the behavioral health industry continues to evolve, consolidation is critical for achieving scale, sustainability, and improved care outcomes,” said Andy Flanagan, CEO of Iris Telehealth. “The acquisition represents a significant step forward for our industry, enabling us to provide our innovative and scalable Virtual Clinic & Iris Insights solutions to health systems and community organizations to deliver improved Behavioral Health outcomes while addressing systemic challenges such as clinician shortages and access disparities.”
